Expression of E-cadherin, β-catenin, and epithelial membrane antigen does not predict survival in patients with high-risk non-muscle-invasive bladder cancer

THE AIM OF THE STUDY: The aim of the study was to validate the value of E-cadherin and β-catenin expression and to test an alternative prognostic marker, epithelial membrane antigen (EMA). MATERIAL AND METHODS: Forty-nine consecutive patients with primary stage T1 non-muscle-invasive bladder cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Poletajew, Sławomir, Fus, Łukasz, Ilczuk, Tomasz, Wojcieszak, Piotr, Sękowska, Małgorzata, Krajewski, Wojciech, Wasiutyński, Aleksander, Górnicka, Barbara, Radziszewski, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Polish Society of Experimental and Clinical Immunology 2018
Materias:
Clinical Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384421/
https://www.ncbi.nlm.nih.gov/pubmed/30799990
http://dx.doi.org/10.5114/ceji.2018.79509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384421/
https://www.ncbi.nlm.nih.gov/pubmed/30799990
http://dx.doi.org/10.5114/ceji.2018.79509

Ejemplares similares